AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 99 filers reported holding AVROBIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,291,655 | -47.4% | 2,412,015 | -44.7% | 0.09% | -49.1% |
Q1 2023 | $4,357,859 | +84.7% | 4,357,859 | +31.7% | 0.17% | +56.9% |
Q4 2022 | $2,359,598 | +5.1% | 3,309,859 | -5.3% | 0.11% | -21.6% |
Q3 2022 | $2,245,000 | -30.2% | 3,494,490 | 0.0% | 0.14% | -31.9% |
Q2 2022 | $3,215,000 | -6.1% | 3,494,490 | +34.7% | 0.20% | -5.1% |
Q1 2022 | $3,425,000 | -65.7% | 2,594,914 | 0.0% | 0.22% | -72.1% |
Q4 2021 | $9,990,000 | -16.1% | 2,594,914 | +21.6% | 0.77% | -26.6% |
Q3 2021 | $11,903,000 | -37.2% | 2,133,214 | 0.0% | 1.05% | -25.8% |
Q2 2021 | $18,964,000 | -4.4% | 2,133,214 | +36.5% | 1.42% | -2.8% |
Q1 2021 | $19,828,000 | – | 1,562,476 | – | 1.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
Western Standard LLC | 310,361 | $477,956 | 0.43% |
Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |